SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
----------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
July 29, 2003
PHASE III MEDICAL, INC.
-----------------------
(Exact name of registrant as specified in its charter)
Delaware
--------
(State or other jurisdiction of incorporation)
0-10909 22-2343568
----------------------------------------------------------------
Commission File Number IRS Employer
Identification No.
330 SOUTH SERVICE ROAD, SUITE 120, Melville, New York 11747
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
631-574-4955
------------
Registrant's Telephone Number
CORNICHE GROUP INCORPORATED
---------------------------
(Former name or former address, if changed since last report.)
ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE
Phase III Medical, Inc. (formerly Corniche Group Incorporated) (the
"Company") issued the press release annexed hereto announcing its new stock
symbols reflecting its new corporate name.
* * * * *
This Report contains forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements represent management's judgment regarding future
events. Although management believes that the expectations reflected in such
statements are reasonable, they give no assurance that such expectations will
prove to be correct and you should be aware that actual results could differ
materially from those contained in the forward-looking statements due to a
number of factors. These factors include the risk that the Company will be
unable to raise capital, to enter successfully or exploit opportunities in the
biotech or medical business, to have appropriate personnel, or the risks
inherent in any new business venture or those detailed in the Company's other
reports filed with the Securities and Exchange Commission. The Company
undertakes no obligation to update or revise the information contained in this
Report whether as a result of new information, future events or circumstances or
otherwise.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
Exhibit 99.1 Press Release
-2-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PHASE III MEDICAL, INC.
By: /s/ Mark Weinreb
-----------------------
Mark Weinreb
President
Dated: July 29, 2003
-3-
Exhibit 99.1
PHASE III MEDICAL, INC. (formerly CORNICHE GROUP)
ANNOUNCES NEW STOCK SYMBOLS
Melville, NY, July 29, 2003. Phase III Medical, Inc. (formerly Corniche Group
Incorporated (OTCBB: CNGI)) today announced its new stock symbols reflecting its
new corporate name. The new ticker symbol for the Common Stock will be PHSM. The
name change and new symbol will become effective on the OTC BB at the opening of
business tomorrow, July 30. In addition, the new ticker symbol for the Series A
preferred stock will be PHSMP.
Last week, the Company announced the change of its corporate name to "Phase III
Medical, Inc." following approval at its Annual Meeting of Shareholders. The
Company has been focusing on entering the medical sector by acquiring or
participating in one or more biotech and/or medical companies or technologies,
owning one or more drugs or medical devices, or acquiring rights to one or more
of such drugs or medical devices or the royalties therefrom.
* * * * *
This Release contains forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995, such
as the Company's ability to enter the medical sector or acquire any companies or
technologies. Forward-looking statements represent management's judgment
regarding future events. Although management believes that the expectations
reflected in such statements are reasonable, it gives no assurance that such
expectations will prove to be correct and you should be aware that actual
results could differ materially from those contained in the forward-looking
statements due to a number of factors. These factors include the risks detailed
in the Company's Annual Report on Form 10-K for the year ended December 31, 2002
and other reports filed with the Securities and Exchange Commission.
For further information please contact:
Mark Weinreb, CEO at 631.574.4955